December 18th 2024
AbbVie's latest acquisition target is Nimble Therapeutics, which will give AbbVie a lead asset, an oral peptide for treating psoriasis.
Roche, Blueprint Medicines Enter $1.7-Billion Deal for Anti-Cancer Drug
July 15th 2020Through the deal, Roche will gain co-commercialization rights to pralsetinib, Blueprint Medicine’s investigational, once-daily oral precision therapy for the treatment of RET-altered non-small cell lung cancer, medullary thyroid cancer, and other types of thyroid cancer
SGS Initiates Clinical Trial of Biophytis’ Treatment for COVID-19 Related Respiratory Failure
July 8th 2020SGS has announced the receipt of approval from Belgium’s Federal Agency for Medicines and Health Products (FAMHP) to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.
Emergent and Johnson & Johnson Enter into $480 Million Manufacturing Agreement for COVID-19 Vaccine
July 6th 2020Emergent is entering into a five-year agreement with Janssen Pharmaceuticals for the large-scale drug substance manufacturing of Johnson & Johnson’s investigational COVID-19 vaccine, Ad26.COV2-S.
CHMP Recommends Marketing Authorization for Triple Combination Therapy for Cystic Fibrosis
July 1st 2020EMA’s Committee for Human Medicinal Products (CHMP) has recommended that Kaftrio, a triple combination therapy for the treatment of cystic fibrosis, be authorized for marketing in the European Union.
Genomics England Launches Next-Generation Genomics Research Platform
July 1st 2020Genomics England (GEL) has announced the launch of a next-generation genomics research platform, supported by Lifebit-a deep tech company-and Amazon Web Services (AWS), which will be primarily dedicated for COVID-19 research.
uniQure, CSL Behring Collaborate on Hemophilia B Gene Therapy in Over $1.6-Billion Deal
June 29th 2020The companies are entering into a license agreement to provide CSL Behring with exclusive global rights to etranacogene dezaparvovec, uniQure’s investigational gene therapy for patients with hemophilia B.
Malvern Panalytical and Concept Life Sciences Launch Amplify Analytics
June 25th 2020The partnership combines Malvern’s physicochemical characterization expertise and Concept Life Sciences’ chemistry and analytical services to provide services that focus on analytics, know-how, instrumentation, and expert support to customers.
Catalent and Moderna Collaborate on Fill/Finish Manufacturing of COVID-19 Vaccine Candidate
June 25th 2020Catalent will offer vial filling, packaging capacity, and additional staffing at the site to support the production of the initial 100 million doses of the vaccine candidate to supply the US market beginning in the third quarter of 2020.
ILC Therapeutics Enters Research Agreement with University of St Andrews
June 25th 2020Biotechnology company, ILC Therapeutics, has revealed that it has entered into a research partnership with the University of St Andrews aimed at progressing a therapeutic drug that can treat COVID-19 to clinical trials.